Johnson & Johnson MedTech Heart Recovery for HCPs

Home
United States
Danvers, MA
Johnson & Johnson MedTech Heart Recovery for HCPs

Providing health care professionals with clinical education and best practices with the ABIOMED® portfolio.

Safety: https://www.abiomed.com/en-us/important-safety-information

06/12/2025

In a recent Thursday Night Live, a multidisciplinary team of physicians from Hackensack University Medical Center discussed how the DanGer Shock RCT validated their cardiogenic shock team and protocols. Watch the full discussion here: https://bit.ly/45gY7HF

06/10/2025

Learn how Impella is designed to maximize blood compatibility, what factors can contribute to hemolysis in the clinical setting, and more with our hemolysis FAQ: https://www.heartrecovery.com/en-us/education/education-library/faq-hemolysis

05/20/2025

This week is !

Did you know that we have educational materials for EMS professionals who transport Impella patients available on our website?

Learn more: https://bit.ly/4k0NFbw

05/10/2025

Happy !

Did you know we offer helpful tools, educational downloads and learning courses for nurses on our website?

Visit today and learn more: https://bit.ly/4kcR6f9

04/22/2025

Case Study Download 🎓📂

A 77-year-old female presented with angina symptoms, multivessel coronary artery disease (CAD) and a moderately depressed ejection fraction (40%). Past history included severe CAD with prior coronary bypass graft surgery (CABG), with no available grafts remaining.

Learn more: https://bit.ly/4jbOTAm

04/16/2025

Get answers to some of the most frequently asked questions about the PROTECT series of clinical studies: https://bit.ly/4j12J8z

04/02/2025

If you're going to Houston Shock this weekend, join us for our "Journey Through Shock" event.

This course is designed to provide you with invaluable insights and practical skills related to understanding and managing cardiogenic shock in various healthcare settings.

Register: https://events.heartrecovery.com/houstonshock2025

03/31/2025

Major Update: Recommendations for MCS in patients with ACS and cardiogenic shock.

The latest ACC/AHA guidelines bring significant changes to the management of Acute Coronary Syndrome (ACS) and Cardiogenic Shock. Impella is now Class 2a in patients with STEMI and severe or refractory cardiogenic shock.

Learn more here: https://bit.ly/4kzEUpT

03/25/2025

Did you know? Cardiogenic shock affects approximately 10% of STEMI patients and has a high early mortality rate of 40–50%.

ACS guidelines can help you identify the right patients for clinical intervention. ACC/AHA guidelines for Acute Coronary Syndrome (ACS) have recently been updated, upgrading Impella® to Class 2a in patients with STEMI and severe or refractory cardiogenic shock.

Learn more here: www.heartrecovery.com/en-us/impella-acc-aha-guidelines

02/24/2025

Thank you to Impella 5.5 patient "Mac" Kelley who shared his story as a special guest at our symposium last week in honor of the first Heart Recovery Awareness Day! And thank you to everyone who attended today's event and visited our booth. ❤️

02/19/2025

If you're at this year, please join us for special symposium held on the first National Heart Recovery Awareness Day! This day has been established through a congressional resolution to be celebrated on February 20.

Address

22 Cherry Hill Drive
Danvers, MA
01923

Website

https://www.heartrecovery.com/

Alerts

Be the first to know and let us send you an email when Johnson & Johnson MedTech Heart Recovery for HCPs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Danvers?